Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation
Objective: To evaluate the efficacy of calcium disodium edetate (CaNa2EDTA) chelation as a treatment for acquired hepatocerebral degeneration. Background: Acquired hepatocerebral degeneration is a rare…Kratom withdrawal induced orobuccal dyskinesia
Objective: To describe the new observation of Kratom withdrawal that presented with the choreiform movement of lips and tongue. Background: Orobuccal dyskinesia is the hyperkinetic…Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico
Objective: Determine the prevalence of systemic and anti-neuronal antibodies in Movement Disorders patients from a third-level neurological hospital. Background: Autoimmunity is a common cause of…Unusual prolonged survival in multiple system atrophy: A case report
Objective: To present a case of a patient with multiple system atrophy (MSA) parkinsonian subtype (MSA-P) with unusual long disease duration. Background: MSA is a…Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?
Objective: To observe if stimulation of deep brain tissue can improve expression of the mouth in Parkinson's disease patients. Background: Masked facies or hypomimia is…The spectrum of abnormal movements and predictors of outcome in anti-NMDA receptor encephalitis in Thai patients
Objective: To describe the spectrum of abnormal movements and predictor of outcome in Thai patients with anti-NMDA receptor (NMDAR) encephalitis. Background: Anti-NMDAR encephalitis mostly presented…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.